SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-005469
Filing Date
2020-03-17
Accepted
2020-03-17 16:06:25
Documents
69
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20191231_10k.htm 10-K 1248767
2 EXHIBIT 4.12 ex_176595.htm EX-4.12 17779
3 EXHIBIT 21.1 ex_176566.htm EX-21.1 4812
4 EXHIBIT 23.1 ex_177424.htm EX-23.1 3532
5 EXHIBIT 31.1 ex_176499.htm EX-31.1 15932
6 EXHIBIT 31.2 ex_176500.htm EX-31.2 15870
7 EXHIBIT 32.1 ex_176501.htm EX-32.1 5980
14 dffn20191231_10kimg003.gif GRAPHIC 19139
15 dffn20191231_10kimg004.gif GRAPHIC 86871
16 dffn20191231_10kimg005.jpg GRAPHIC 9717
17 dffn20191231_10kimg006.jpg GRAPHIC 28630
18 img01.jpg GRAPHIC 22681
19 picture1.jpg GRAPHIC 61938
  Complete submission text file 0001437749-20-005469.txt   4961585

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dffn-20191231.xml EX-101.INS 781035
9 XBRL TAXONOMY EXTENSION SCHEMA dffn-20191231.xsd EX-101.SCH 48356
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20191231_cal.xml EX-101.CAL 33555
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20191231_def.xml EX-101.DEF 299546
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20191231_lab.xml EX-101.LAB 291062
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20191231_pre.xml EX-101.PRE 329215
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 20720977
SIC: 2834 Pharmaceutical Preparations